Sanatorio Allende (Nueva Córdoba)

Hipolito Yrigoyen 384, Córdoba

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Maria Gimena Ferreira

Maria Sol Jarchum

Stefano Kim

Maria Garcia de la Vega

Hernan Curuchet

Ignacio Jerez

Diego Abellan Von Farkas

Gustavo Jarchum

Alberto Guillermo Liberman

Myriam Giselle Martini de Nores

Eduardo Horacio Albiero

Jesica Bofer

Mariano Gottero

Cintia Otaduy

Open studies

Breast Cancer

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) - MK-2870-032 - Merck Sharp & Dohme LLCSee more

A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) - PionERA - Hoffmann-La RocheSee more

Stroke

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE - LIBREXIASTROKE - Janssen Research & Development, LLCSee more

Hemolytic uremic syndrome

Efficacy of INM004 in Children With STEC-HUS - Inmunova S.A.See more

Nephropathy

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression - IMAGINATION - Hoffmann-La RocheSee more

Lung cancer

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC - ALKAZAR - Nuvalent Inc.See more

Colorectal cancer

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation - CodeBreaK 301 - AmgenSee more

Pancreatic cancer

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30) - MountainTAP-30 - Bristol-Myers SquibbSee more

Leukemia

A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL - AmgenSee more